Drug Channels
SEPTEMBER 22, 2023
In this article, Kristina reviews how brands can help patients make connections that address medication affordability challenges, whether at the prescriber’s office, the pharmacy, or at home. Read on for Kristina’s insights. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.
Drug Channels
SEPTEMBER 22, 2023
In this article, Kristina reviews how brands can help patients make connections that address medication affordability challenges, whether at the prescriber’s office, the pharmacy, or at home. Read on for Kristina’s insights. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Conversations in Drug Development Trends
FEBRUARY 21, 2024
We recently published a white paper discussing the value of proactive AME studies, best practices, and lessons we’ve learned over the years to help optimize your study. Dosing Our pharmacy services can prepare liquid, solid, and intravenous dosage formulations. Here are a few of our lessons learned: 1.
Drug Channels
FEBRUARY 23, 2021
In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar! Plus, entrepreneurial pharmacy owner Dave Marley demonstrates the power of innovation. See page 15 (reproduced below).
The Pharma Data
NOVEMBER 20, 2020
According to a benchmarking survey by TraceLink , 532 global supply chain leaders from various leading pharma companies, wholesale distributors, hospitals and pharmacies have indicated the supply chain has been severely impacted by the Covid-19 pandemic.
Agency IQ
APRIL 12, 2024
ACRO’s white paper also highlights the potential for “enhanced efficiency, long-term cost savings, and faster collection of data” through risk-based monitoring and other data collection efficiencies.
FDA Law Blog: Biosimilars
APRIL 8, 2024
Department of Health and Human Services (HHS) recently published a White Paper on Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States —with input from several HHS stakeholders, including FDA, CMS, and the Administration for Strategic Preparedness and Response. By Kalie E.
Expert insights. Personalized for you.
98 
Let's personalize your content